Drug firm Ipca Laboratories Wednesday said it has entered into a pact to buy Maharashtra-based Ramdev Chemical for Rs 108.5 crore.
The company has entered into a share purchase agreement (SPA) to acquire 100 per cent paid-up share capital of Ramdev Chemical Pvt Ltd (RCPL), Ipca Laboratories said in a regulatory filing.
RCPL is engaged in manufacturing and marketing of advanced drug intermediates, fine chemicals, custom synthesis molecules and active pharmaceutical ingredients (APIs).
The acquisition will help the company grow its API business by adding new molecules with possibility of forward integrating such products in its dosage formulations business for the global markets, it added.
RCPL's registered office and manufacturing unit is located in the Palghar district of Maharashtra.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app